Transcode Therapeutics Inc (RNAZ) — Cash Flow Quality Index

Latest as of June 2021: -0.06x

Transcode Therapeutics Inc (RNAZ) has a Cash Flow Quality Index of -0.06x as of June 2021. Operating cash flow of $-161.66K is below net income of $2.77 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore RNAZ asset base for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.06x

Operating CF / Net Income

Operating Cash Flow

$-161.66K

USD

Net Income

$2.77 Million

USD

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for Transcode Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Transcode Therapeutics Inc. For live market cap and the full company financial profile, see RNAZ market cap.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.